2023 Vol.41, N°3 - Table of contents
March 2023
Recommendations
CER16640
2023,41,3
Pg. 0543-0553
Free to view
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
R. Talarico, G.A. Ramirez, S.C. Barreira, C. Cardamone, P. Triggianese, S. Aguilera, J. Andersen, T. Avcin, K. Benistan, G. Bertsias, A. Bortoluzzi, C. Bouillot, I. Bulina, G.R. Burmester, S. Callens, P.E. Carreira, R. Cervera, M. Cutolo, L. Damian, E. Della-Torre, R. Faria, J.E. Fonseca, I. Galetti, E. Hachulla, L. Iaccarino, S. Jacobsen, N. Khmelinskii, M. Limper, D. Marinello, A. Meyer, G. Moroncini, G. Nagy, M. Olesinska, C. Pamfil, M. Pileckyte, M. Pistello, S. Rednic, C. Richez, V.C. Romão, M. Schneider, S. Sciascia, C.A. Scirè, G. Simonini, V. Smith, A. Sulli, C. Tani, S.W. Tas, A. Tincani, M.C. Vonk, M. Tektonidou, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/jpargp
R. Talarico, G.A. Ramirez, S.C. Barreira, C. Cardamone, P. Triggianese, S. Aguilera, J. Andersen, T. Avcin, K. Benistan, G. Bertsias, A. Bortoluzzi, C. Bouillot, I. Bulina, G.R. Burmester, S. Callens, P.E. Carreira, R. Cervera, M. Cutolo, L. Damian, E. Della-Torre, R. Faria, J.E. Fonseca, I. Galetti, E. Hachulla, L. Iaccarino, S. Jacobsen, N. Khmelinskii, M. Limper, D. Marinello, A. Meyer, G. Moroncini, G. Nagy, M. Olesinska, C. Pamfil, M. Pileckyte, M. Pistello, S. Rednic, C. Richez, V.C. Romão, M. Schneider, S. Sciascia, C.A. Scirè, G. Simonini, V. Smith, A. Sulli, C. Tani, S.W. Tas, A. Tincani, M.C. Vonk, M. Tektonidou, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/jpargp
One year in review
CER16652
2023,41,3
Pg. 0554-0564
Free to view
Seronegative rheumatoid arthritis: one year in review 2023
L. De Stefano, B. D'onofrio, S. Gandolfo, E. Bozzalla Cassione, D. Mauro, A. Manzo, F. Ciccia, S. Bugatti
DOI: https://doi.org/10.55563/clinexprheumatol/go7g26
L. De Stefano, B. D'onofrio, S. Gandolfo, E. Bozzalla Cassione, D. Mauro, A. Manzo, F. Ciccia, S. Bugatti
DOI: https://doi.org/10.55563/clinexprheumatol/go7g26
Full Papers
CER15475
2023,41,3
Pg. 0565-0573
Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors
B. Hernández-Breijo, M. Novella-Navarro, F. Genre, V. Navarro-Compán, A. Martínez-Feito, S. Remuzgo-Martínez, M.Á. González-Gay, A. Balsa, C. Plasencia-Rodríguez
DOI: https://doi.org/10.55563/clinexprheumatol/ou570o
B. Hernández-Breijo, M. Novella-Navarro, F. Genre, V. Navarro-Compán, A. Martínez-Feito, S. Remuzgo-Martínez, M.Á. González-Gay, A. Balsa, C. Plasencia-Rodríguez
DOI: https://doi.org/10.55563/clinexprheumatol/ou570o
CER15506
2023,41,3
Pg. 0574-0580
Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers
S. Holm Nielsen, C. Magee, S.S. Groen, D. Sinkevičiūtė, A.C. Bay-Jensen, M.A. Karsdal, S.R. Pennington, O. Fitzgerald
DOI: https://doi.org/10.55563/clinexprheumatol/jmt9jv
S. Holm Nielsen, C. Magee, S.S. Groen, D. Sinkevičiūtė, A.C. Bay-Jensen, M.A. Karsdal, S.R. Pennington, O. Fitzgerald
DOI: https://doi.org/10.55563/clinexprheumatol/jmt9jv
CER15040
2023,41,3
Pg. 0581-0588
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies
P. Conigliaro, C. Giannini, S. Ferrigno, C. Nesi, G.L. Fonti, M.S. Chimenti, P. Triggianese, F. Aiello, C. Nucci, A. Bergamini, M. Cesareo
DOI: https://doi.org/10.55563/clinexprheumatol/p1q482
P. Conigliaro, C. Giannini, S. Ferrigno, C. Nesi, G.L. Fonti, M.S. Chimenti, P. Triggianese, F. Aiello, C. Nucci, A. Bergamini, M. Cesareo
DOI: https://doi.org/10.55563/clinexprheumatol/p1q482
CER15551
2023,41,3
Pg. 0589-0596
Free to view
Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study
B. Kirkham, P. Nash, D. Reina, S. Navarra, E. Quebe-Fehling, C. Gaillez, C. Sastre, P.J. Mease
DOI: https://doi.org/10.55563/clinexprheumatol/vezf95
B. Kirkham, P. Nash, D. Reina, S. Navarra, E. Quebe-Fehling, C. Gaillez, C. Sastre, P.J. Mease
DOI: https://doi.org/10.55563/clinexprheumatol/vezf95
CER15471
2023,41,3
Pg. 0597-0604
Free to view
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol
S. Sciascia, M. Radin, I. Cecchi, A. Barinotti, E. Rubini, D. Rossi, R. Fenoglio, A. Vaccarino, E. Menegatti, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/qa2yb4
S. Sciascia, M. Radin, I. Cecchi, A. Barinotti, E. Rubini, D. Rossi, R. Fenoglio, A. Vaccarino, E. Menegatti, D. Roccatello
DOI: https://doi.org/10.55563/clinexprheumatol/qa2yb4
CER15635
2023,41,3
Pg. 0605-0612
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome
P. Gaspar, F. Farinha, Z. Sayar, M. Efthymiou, H. Cohen, D.A. Isenberg
DOI: https://doi.org/10.55563/clinexprheumatol/0gs167
P. Gaspar, F. Farinha, Z. Sayar, M. Efthymiou, H. Cohen, D.A. Isenberg
DOI: https://doi.org/10.55563/clinexprheumatol/0gs167
CER15512
2023,41,3
Pg. 0613-0619
Free to view
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
R. Scrivo, C. Castellani, S. Mancuso, G. Sciarra, F. Giardina, G. Bevignani, F. Ceccarelli, F.R. Spinelli, C. Alessandri, M. Di Franco, V. Riccieri, R. Priori, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/bf00j9
R. Scrivo, C. Castellani, S. Mancuso, G. Sciarra, F. Giardina, G. Bevignani, F. Ceccarelli, F.R. Spinelli, C. Alessandri, M. Di Franco, V. Riccieri, R. Priori, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/bf00j9
CER15388
2023,41,3
Pg. 0620-0627
Free to view
Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?
P. Atagündüz, S. Kiraz, S. Akar, O. Küçükşahin, A. Erden, A. Aksoy, B.N. Coşkun, B. Yağiz, C. Bes, N. Alpay Kanitez, L. Kilic, Ö. Karadağ, T. Kaşifoğlu, H. Emmungil, M. Cinar, G. Kimyon, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/eb1zpo
P. Atagündüz, S. Kiraz, S. Akar, O. Küçükşahin, A. Erden, A. Aksoy, B.N. Coşkun, B. Yağiz, C. Bes, N. Alpay Kanitez, L. Kilic, Ö. Karadağ, T. Kaşifoğlu, H. Emmungil, M. Cinar, G. Kimyon, V. Yazisiz, A. Ateş, D. Ersözlü, E. Gönüllü, R. Mercan, İ. Ertenli, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/eb1zpo
CER15625
2023,41,3
Pg. 0628-0633
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
M. Lorenzin, N. Ughi, A. Ariani, B. Raffeiner, P. Frallonardo, A. Hoxha, A. Ortolan, M. Favero, S. Parisi, A. Bortoluzzi, F. Ceccarelli, R. Lucchetti, F. Furini, T. Del Ross, A. Zanetti, G. Carrara, C.A. Scirè, A. Doria, R. Ramonda
Collaborator/s: F. Salaffi, A. Di Matteo, E. Fusaro, M. Govoni, M. Manara, A. Murgo, L. Rotunno, M.A. Cimmino
on behalf of the SIR Study Group ATTACk
DOI: https://doi.org/10.55563/clinexprheumatol/eh0jcp
M. Lorenzin, N. Ughi, A. Ariani, B. Raffeiner, P. Frallonardo, A. Hoxha, A. Ortolan, M. Favero, S. Parisi, A. Bortoluzzi, F. Ceccarelli, R. Lucchetti, F. Furini, T. Del Ross, A. Zanetti, G. Carrara, C.A. Scirè, A. Doria, R. Ramonda
Collaborator/s: F. Salaffi, A. Di Matteo, E. Fusaro, M. Govoni, M. Manara, A. Murgo, L. Rotunno, M.A. Cimmino
on behalf of the SIR Study Group ATTACk
DOI: https://doi.org/10.55563/clinexprheumatol/eh0jcp
CER15489
2023,41,3
Pg. 0634-0641
Decreased perforin-producing B cells correlate with systemic lupus erythematosus
M. Bai, L. Xu, Z. Zhao, J. Xue, H. Zhong, T. Liu, F. Sun, H. Yao, F. Hu, Y. Su
DOI: https://doi.org/10.55563/clinexprheumatol/s16m7j
M. Bai, L. Xu, Z. Zhao, J. Xue, H. Zhong, T. Liu, F. Sun, H. Yao, F. Hu, Y. Su
DOI: https://doi.org/10.55563/clinexprheumatol/s16m7j
CER15414
2023,41,3
Pg. 0642-0648
Free to view
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
M. Gasparotto, S. Bindoli, R. Padoan, G. Cozzi, R. Depascale, E. Zanatta, A. Giollo, M. Gatto, M. Zen, F. Schiavon, R. Ramonda, P. Sfriso, A. Doria, L. Iaccarino
DOI: https://doi.org/10.55563/clinexprheumatol/vx44zn
M. Gasparotto, S. Bindoli, R. Padoan, G. Cozzi, R. Depascale, E. Zanatta, A. Giollo, M. Gatto, M. Zen, F. Schiavon, R. Ramonda, P. Sfriso, A. Doria, L. Iaccarino
DOI: https://doi.org/10.55563/clinexprheumatol/vx44zn
CER15651
2023,41,3
Pg. 0649-0655
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort
D. Guellec, G. Carvajal-Alegria, C. Daïen, L. Gossec, F. Guillemin, F. Berenbaum, A. Constantin, P. Dieude, M. Dougados, R.M. Flipo, P. Goupille, X. Mariette, C. Richez, O. Vittecoq, B. Combe, A. Saraux
DOI: https://doi.org/10.55563/clinexprheumatol/bdcl06
D. Guellec, G. Carvajal-Alegria, C. Daïen, L. Gossec, F. Guillemin, F. Berenbaum, A. Constantin, P. Dieude, M. Dougados, R.M. Flipo, P. Goupille, X. Mariette, C. Richez, O. Vittecoq, B. Combe, A. Saraux
DOI: https://doi.org/10.55563/clinexprheumatol/bdcl06
CER15643
2023,41,3
Pg. 0656-0666
Free to view
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres
D. Vogler, P. Ruscitti, L. Navarini, R. Giacomelli, A. Iagnocco, P. Hoff, G.-R. Burmester, S. Ohrndorf
DOI: https://doi.org/10.55563/clinexprheumatol/an1yrh
D. Vogler, P. Ruscitti, L. Navarini, R. Giacomelli, A. Iagnocco, P. Hoff, G.-R. Burmester, S. Ohrndorf
DOI: https://doi.org/10.55563/clinexprheumatol/an1yrh
CER15485
2023,41,3
Pg. 0667-0675
Free to view
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
L. De Stefano, S. Balduzzi, L. Bogliolo, B. D'onofrio, M. Di Lernia, E. Mauric, A. Milanesi, F. Brandolino, C. Rocca, S. Chiricolo, A. Manzo, C. Montecucco, S. Bugatti
DOI: https://doi.org/10.55563/clinexprheumatol/0ltj1i
L. De Stefano, S. Balduzzi, L. Bogliolo, B. D'onofrio, M. Di Lernia, E. Mauric, A. Milanesi, F. Brandolino, C. Rocca, S. Chiricolo, A. Manzo, C. Montecucco, S. Bugatti
DOI: https://doi.org/10.55563/clinexprheumatol/0ltj1i
CER15751
2023,41,3
Pg. 0676-0684
Free to view
Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE
E.S. Larsen, A.C. Nilsson, S. Möller, A.B. Voss, I.S. Johansen
DOI: https://doi.org/10.55563/clinexprheumatol/b8a6zb
E.S. Larsen, A.C. Nilsson, S. Möller, A.B. Voss, I.S. Johansen
DOI: https://doi.org/10.55563/clinexprheumatol/b8a6zb
CER15620
2023,41,3
Pg. 0685-0693
Free to view
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases
M. Fredi, L.M. Argolini, F. Angeli, L. Trespidi, V. Ramoni, S. Zatti, T. Vojinovic, D. Donzelli, F.G. Gazzola, B. Xoxi, L. Andreoli, A. Lojacono, E. Ferrazzi, C. Montecucco, C.B. Chighizola, P.L. Meroni, F. Franceschini, R. Cimaz, R. Caporali, A. Tincani, M. Gerosa
DOI: https://doi.org/10.55563/clinexprheumatol/2ju0yv
M. Fredi, L.M. Argolini, F. Angeli, L. Trespidi, V. Ramoni, S. Zatti, T. Vojinovic, D. Donzelli, F.G. Gazzola, B. Xoxi, L. Andreoli, A. Lojacono, E. Ferrazzi, C. Montecucco, C.B. Chighizola, P.L. Meroni, F. Franceschini, R. Cimaz, R. Caporali, A. Tincani, M. Gerosa
DOI: https://doi.org/10.55563/clinexprheumatol/2ju0yv
CER15419
2023,41,3
Pg. 0694-0703
Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis
T. Rabin, G. De Marco, S.R. Dubash, F. Shuweihdi, H. Marzo-Ortega, P. Emery, F. Ponchel, V. Goeb
DOI: https://doi.org/10.55563/clinexprheumatol/5epyh7
T. Rabin, G. De Marco, S.R. Dubash, F. Shuweihdi, H. Marzo-Ortega, P. Emery, F. Ponchel, V. Goeb
DOI: https://doi.org/10.55563/clinexprheumatol/5epyh7
CER15690
2023,41,3
Pg. 0704-0710
Can numerical rating scales of disease impact be used as targets for patient-centred management in rheumatoid arthritis?
C. Duarte, E. Santos, S.C. Barreira, P. Ávila-Ribeiro, F. Costa, P. Freitas, F. Araújo, R. Freitas, J. Marona, S.R. Manica, J. Ferreira, M. Couto, M. Guerra, L.H. Calabrese, M. De Wit, R.J. Ferreira, J.A. Da Silva
DOI: https://doi.org/10.55563/clinexprheumatol/8xdgxu
C. Duarte, E. Santos, S.C. Barreira, P. Ávila-Ribeiro, F. Costa, P. Freitas, F. Araújo, R. Freitas, J. Marona, S.R. Manica, J. Ferreira, M. Couto, M. Guerra, L.H. Calabrese, M. De Wit, R.J. Ferreira, J.A. Da Silva
DOI: https://doi.org/10.55563/clinexprheumatol/8xdgxu
CER15701
2023,41,3
Pg. 0711-0717
Association between serum free fatty acid levels and tophus in patients with gout: a cross‐sectional study
K. Si, C. Wei, L. Xu, W. Lv, B. Dong, Z. Wang, Y. Huang, Y. Chen, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/a3i566
K. Si, C. Wei, L. Xu, W. Lv, B. Dong, Z. Wang, Y. Huang, Y. Chen, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/a3i566
CER15564
2023,41,3
Pg. 0718-0726
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study
V.I. Mazurov, T.V. Dubinina, S. Erdes, S.A. Lapshina, N.F. Soroka, E.V. Kunder, A.V. Smirnov, A.V. Eremeeva, A.V. Zinkina-Orikhan, M.A. Morozova, I.Z. Gaydukova
DOI: https://doi.org/10.55563/clinexprheumatol/ljpqqe
V.I. Mazurov, T.V. Dubinina, S. Erdes, S.A. Lapshina, N.F. Soroka, E.V. Kunder, A.V. Smirnov, A.V. Eremeeva, A.V. Zinkina-Orikhan, M.A. Morozova, I.Z. Gaydukova
DOI: https://doi.org/10.55563/clinexprheumatol/ljpqqe
CER15782
2023,41,3
Pg. 0727-0734
Free to view
Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis
R. Garofoli, M. Resche-Rigon, C. Roux, D. Van Der Heijde, M. Dougados, A. Moltó
DOI: https://doi.org/10.55563/clinexprheumatol/mm2uzu
R. Garofoli, M. Resche-Rigon, C. Roux, D. Van Der Heijde, M. Dougados, A. Moltó
DOI: https://doi.org/10.55563/clinexprheumatol/mm2uzu
CER15663
2023,41,3
Pg. 0735-0743
Free to view
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort
E. Gremese, F. Ciccia, C. Selmi, G. Cuomo, R. Foti, M. Matucci-Cerinic, F. Conti, E. Fusaro, G. Guggino, F. Iannone, A. Delle Sedie, R. Perricone, L. Idolazzi, P. Moscato, E. Theander, W. Noël, P. Bergmans, S. Marelli, L. Gossec, J.S. Smolen
Collaborator/s: P. Sarzi-Puttini, G. Ferraccioli, C. Galeone
Italian PsABio study
DOI: https://doi.org/10.55563/clinexprheumatol/j33pjt
E. Gremese, F. Ciccia, C. Selmi, G. Cuomo, R. Foti, M. Matucci-Cerinic, F. Conti, E. Fusaro, G. Guggino, F. Iannone, A. Delle Sedie, R. Perricone, L. Idolazzi, P. Moscato, E. Theander, W. Noël, P. Bergmans, S. Marelli, L. Gossec, J.S. Smolen
Collaborator/s: P. Sarzi-Puttini, G. Ferraccioli, C. Galeone
Italian PsABio study
DOI: https://doi.org/10.55563/clinexprheumatol/j33pjt
Brief Paper
CER15682
2023,41,3
Pg. 0744-0746
Free to view
Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction
R. Daood, K. Toledano, D. Markovits, Y. Tavor, S. Giryes, K. Dolnikov, H. Jeries, A. Balbir-Gurman, Y. Braun-Moscovici
DOI: https://doi.org/10.55563/clinexprheumatol/lxfy2v
R. Daood, K. Toledano, D. Markovits, Y. Tavor, S. Giryes, K. Dolnikov, H. Jeries, A. Balbir-Gurman, Y. Braun-Moscovici
DOI: https://doi.org/10.55563/clinexprheumatol/lxfy2v
Paediatric Rheumatology
CER15497
2023,41,3
Pg. 0747-0752
Free to view
Clinical characteristics of 1020 childhood-onset systemic lupus erythematosus: data from a health centre in China
S. Li, Y. Xue, W. Kuang, B. Sun, H. Liu, J. Deng, J. Zhang, X. Tan, C. Li, X. Zhao, X. Luo, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/eip0au
S. Li, Y. Xue, W. Kuang, B. Sun, H. Liu, J. Deng, J. Zhang, X. Tan, C. Li, X. Zhao, X. Luo, C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/eip0au
CER15982
2023,41,3
Pg. 0753-0757
Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus
H. Kilic, S. Sahin, M.F. Toprak, G.H. Hatay, K. Yilmaz, A. Adrovic, K. Barut, E. Ozturk Isik, E. Tuzun, O. Kizilkilic, S. Saltik, O. Kasapcopur
DOI: https://doi.org/10.55563/clinexprheumatol/7pgsnc
H. Kilic, S. Sahin, M.F. Toprak, G.H. Hatay, K. Yilmaz, A. Adrovic, K. Barut, E. Ozturk Isik, E. Tuzun, O. Kizilkilic, S. Saltik, O. Kasapcopur
DOI: https://doi.org/10.55563/clinexprheumatol/7pgsnc
Letters to the Editor
CER16132
2023,41,3
Pg. 0758-0759
Free to view
Factors influencing the course of COVID-19 in the inflammatory rheumatic diseases
S. Celik, M.E. Kutu, C. Bal, B. Karadeniz, P. Atagunduz, M. Soy
DOI: https://doi.org/10.55563/clinexprheumatol/3pcfrz
S. Celik, M.E. Kutu, C. Bal, B. Karadeniz, P. Atagunduz, M. Soy
DOI: https://doi.org/10.55563/clinexprheumatol/3pcfrz
CER15783
2023,41,3
Pg. 0760-0761
Free to view
Intracranial calcification in systemic lupus erythematosus: a rare condition that needs more attention
Y. Hu, Y. Zhao, H. Zeng, Q. Jin, T. Liu, Q. Yang, D. Fox, C. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/y7vtkl
Y. Hu, Y. Zhao, H. Zeng, Q. Jin, T. Liu, Q. Yang, D. Fox, C. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/y7vtkl
CER16342
2023,41,3
Pg. 0762
Free to view
Comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver
W. Wang, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/tfggsk
W. Wang, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/tfggsk
CER16406
2023,41,3
Pg. 0762
Free to view
Reply to comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver
I. Andreica, X. Baraliakos, J. Braun
DOI: https://doi.org/10.55563/clinexprheumatol/de3qq9
I. Andreica, X. Baraliakos, J. Braun
DOI: https://doi.org/10.55563/clinexprheumatol/de3qq9
CER16249
2023,41,3
Pg. 0763-0764
Free to view
Successful treatment of eosinophilic fasciitis with the anti-IL5 receptor monoclonal antibody benralizumab
C. Rizzo, L. La Barbera, F. Camarda, G.M. Destro Castaniti, E. Orlando, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/oxy3ip
C. Rizzo, L. La Barbera, F. Camarda, G.M. Destro Castaniti, E. Orlando, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/oxy3ip
Book review
CER16698
2023,41,3
Pg. 0764
Free to view
Book review: Passion for excellence, my long life journey into medicine and public life, by H.M. Moutsopoulos
C.V. Massalas
DOI: https://doi.org/10.55563/clinexprheumatol/qhodag
C.V. Massalas
DOI: https://doi.org/10.55563/clinexprheumatol/qhodag